Andy Bayliss is a senior technical account manager at SAS working with many of their large pharmaceutical and life science companies. In his spare time, he is a keen cyclist and is constantly planning his next cycling adventure. He can be reached at Andy.Bayliss@sas.com
Getting a new medicine to market is a marathon, not a sprint. Or perhaps a better analogy is a steeplechase, where competitors must overcome gruelling obstacles on their way to the finish line. Clinical trials are one of the biggest hurdles on the route to market and they’re getting more
In my previous post, I shared how I’ve been working on a fascinating project with one of the world's largest pharmaceutical companies. The company is applying SAS Viya computer vision capabilities to an advanced medical device to help identify potential quality issues on the production line. By providing 100% visual
Over the past few months, I’ve been working on a fascinating project with one of the world's largest pharmaceutical companies to apply SAS Viya computer vision to help identify potential quality issues on the production line as part of the validated inspection process. As I know the application of these
